Mustang Bio, INC. (MBIO) — 10-Q Filings

10-Q Filings (6)

• Mustang Bio Narrows Losses, Boosts Cash Amid Going Concern Doubts — Nov 7, 2025 Risk: high
  MUSTANG BIO, INC. (MBIO) reported a net loss of $468,000 for the three months ended September 30, 2025, a significant improvement from the $1.41 million net los
• Mustang Bio Navigates Cash Burn, Leans on Equity for Survival — Aug 8, 2025 Risk: high
  MUSTANG BIO, INC. reported no revenue for the three and six months ended June 30, 2025, consistent with its pre-commercial stage. The company's net loss for the
• Mustang Bio Files Q1 2025 10-Q — May 14, 2025 Risk: medium
  Mustang Bio, Inc. filed its 10-Q for the period ending March 31, 2025. The company's financial statements show details regarding its common stock, additional pa
• Mustang Bio Files Q3 2024 10-Q — Nov 8, 2024 Risk: medium
  Mustang Bio, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results and operational highlights. Key financial
• Mustang Bio Reports Q2 2024 Results, Equity Offerings — Aug 13, 2024 Risk: medium
  Mustang Bio, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported total assets of $34.1 million and total liabilities of $8.45 million.
• Mustang Bio, Inc. Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: medium
  MUSTANG BIO, INC. (MBIO) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Mustang Bio reported total assets of $11,253,767 as of March 31, 2024. Th

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX